Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

LeukoSite and Medarex expand HuMab-Mouse licensing agreement

March 2, 1999

Atrix expands drug delivery patent portfolio

March 1, 1999

Palatin awarded 4th and 5th SBIR grants for MIDAS technology

March 1, 1999

Aurora enters screening agreement with Roche

Feb. 26, 1999

Biogen and Ontogeny extend hedgehog protein collaboration

Feb. 26, 1999

Merck terminates negotiations with Bioject

Feb. 26, 1999

Aurora enters assay development and screening agreement with P&U

Feb. 25, 1999

Protein Sciences, Texas A&M combine intellectual property positions on BEVS

Feb. 24, 1999

Anesta enters agreement with Novartis for transmucosal drug delivery

Feb. 24, 1999

DiagnoCure plans preclinical trials of its patented vectors in melanoma

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...